The American Heart Association is seeking 10 investigators or investigative teams to award $100,000 apiece through its “From Heart to Head to Hormones” campaign.” In partnership with the Studio Red/Go Red for Women Fund, AHA is prioritizing innovative technologies that “disproportionally or exclusively” impact women’s health, including ischemia, certain kinds of cardiovascular disease, autoimmune disease, endometriosis and heavy menstrual bleeding. “Despite significant progress in biomedical research, many conditions that disproportionately, differently, or distinctly impact women remain underdiagnosed, undertreated, and underfunded,” AHA notes, adding that cardiovascular disease is the leading cause of death in women. “This call focuses on priority areas where transformative science and innovation are urgently needed.”